Regulatory

Feb 14, 2018
Advocates on all sides applauded the request to increase funding significantly for FDA under the Trump administration’s budget for fiscal year 2019.
Feb 08, 2018
Commissioner Scott Gottlieb this week outlined FDA plans to continue the fight against opioid addiction and to prepare a “comprehensive plan” to bolster the market for biosimilars.
Feb 06, 2018
Pharmaceutical Executive
Low-cost follow-ons and biosimilars please payers but heighten competitive battles with brands.
Feb 01, 2018
In his State-of-the-Union address this week, President Trump continued his harangue about unfair drug prices in the U.S., but he surprised many observers by failing to call for full repeal of the Affordable Care Act.
Jan 24, 2018
Reflector reports on the EU's legislative move to push the fifty or so national and regional HTA organizations in Europe towards greater cooperation.
Jan 10, 2018
If confirmed as the next secretary of the Department of Health and Human Services (HHS), Alex Azar says that a top priority is to make drugs more affordable.
Dec 31, 2017
Enacting landmark tax reform legislation that makes major changes in the corporate tax structure was Congress's Christmas present to President Trump — and to industry, writes Jill Wechsler.
Nov 30, 2017
Experts slam drug prices and endorse government price negotiations and curbs on drug advertising.
Nov 27, 2017
Halfway through the process for establishing a national electronic drug tracking system, there’s concern among pharma companies, distributors, and pharmacists about meeting the 2023 deadline
Nov 22, 2017
Jill Wechsler discusses the hot topic of how FDA should oversee combination products that incorporate a digital health component.
native1_300x100
lorem ipsum